Validation of RCC Predicting Model With Emulated-target Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Validation of RCC Predicting Model With Emulated-target Trial — Stella

Home/Renal Cell Carcinoma (Kidney Cancer)/

View on ClinicalTrials.gov

Recruiting

Back to Renal Cell Carcinoma (Kidney Cancer) trials

Trial locations(1 site)

China

Peking University Third Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Peking University Third Hospital

Enrollment target

~4,700 participants

Started

September 2025

Primary completion

February 2027

Age range

18 Years – 80 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.